Literature DB >> 11279250

Angiotensin II-induced stimulation of p21-activated kinase and c-Jun NH2-terminal kinase is mediated by Rac1 and Nck.

U Schmitz1, K Thömmes, I Beier, W Wagner, A Sachinidis, R Düsing, H Vetter.   

Abstract

p21-activated kinase (PAK) has been shown to be an upstream mediator of JNK in angiotensin II (AngII) signaling. Little is known regarding other signaling molecules involved in activation of PAK and JNK by AngII. Rho family GTPases Rac and Cdc42 have been shown to enhance PAK activity by binding to p21-binding domain of PAK (PAK-PBD). In vascular smooth muscle cells (VSMC) AngII stimulated Rac1 binding to GST-PAK-PBD fusion protein. Pretreatment of VSMC by genistein inhibited AngII-induced Rac1 activation, whereas Src inhibitor PP1 had no effect. Inhibition of protein kinase C by phorbol 12,13-dibutyrate pretreatment also decreased AngII-mediated activation of Rac1. The adaptor molecule Nck has been shown previously to mediate PAK activation by facilitating translocation of PAK to the plasma membrane. In VSMC AngII stimulated translocation of Nck and PAK to the membrane fraction. Overexpression of dominant-negative Nck in Chinese hamster ovary (CHO) cells, stably expressing the AngII type I receptor (CHO-AT1), inhibited both PAK and JNK activation by AngII, whereas it did not affect ERK1/2. Finally, dominant-negative Nck inhibited AngII-induced DNA synthesis in CHO-AT1 cells. Our data provide evidence for Rac1 and Nck as upstream mediators of PAK and JNK in AngII signaling and implicate JNK in AngII-induced growth responses.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11279250     DOI: 10.1074/jbc.M102450200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Syk regulates multiple signaling pathways leading to CX3CL1 chemotaxis in macrophages.

Authors:  Haein Park; Dianne Cox
Journal:  J Biol Chem       Date:  2011-03-09       Impact factor: 5.157

2.  Src and FAK kinases cooperate to phosphorylate paxillin kinase linker, stimulate its focal adhesion localization, and regulate cell spreading and protrusiveness.

Authors:  Michael C Brown; Leslie A Cary; Jennifer S Jamieson; Jonathan A Cooper; Christopher E Turner
Journal:  Mol Biol Cell       Date:  2005-07-06       Impact factor: 4.138

3.  p21-activated kinase improves cardiac contractility during ischemia-reperfusion concomitant with changes in troponin-T and myosin light chain 2 phosphorylation.

Authors:  Michelle M Monasky; Domenico M Taglieri; Bindiya G Patel; Jonathan Chernoff; Beata M Wolska; Yunbo Ke; R John Solaro
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-10-28       Impact factor: 4.733

Review 4.  Role of Rac1-mineralocorticoid-receptor signalling in renal and cardiac disease.

Authors:  Miki Nagase; Toshiro Fujita
Journal:  Nat Rev Nephrol       Date:  2013-01-08       Impact factor: 28.314

5.  Inhibition of Endocytosis of Clathrin-Mediated Angiotensin II Receptor Type 1 in Podocytes Augments Glomerular Injury.

Authors:  Kazunori Inoue; Xuefei Tian; Heino Velazquez; Keita Soda; Zhen Wang; Christopher E Pedigo; Ying Wang; Elizabeth Cross; Marwin Groener; Jee-Won Shin; Wei Li; Hossam Hassan; Koichi Yamamoto; Peter Mundel; Shuta Ishibe
Journal:  J Am Soc Nephrol       Date:  2019-09-11       Impact factor: 10.121

6.  p21-activated kinase 1 participates in vascular remodeling in vitro and in vivo.

Authors:  Akinari Hinoki; Keita Kimura; Sadaharu Higuchi; Kunie Eguchi; Akira Takaguri; Kazuhiro Ishimaru; Gerald D Frank; William T Gerthoffer; Laura J Sommerville; Michael V Autieri; Satoru Eguchi
Journal:  Hypertension       Date:  2009-11-09       Impact factor: 10.190

7.  Inhibition of contraction and myosin light chain phosphorylation in guinea-pig smooth muscle by p21-activated kinase 1.

Authors:  A Wirth; M Schroeter; C Kock-Hauser; E Manser; J M Chalovich; P De Lanerolle; G Pfitzer
Journal:  J Physiol       Date:  2003-04-11       Impact factor: 5.182

8.  Involvement of betaPIX in angiotensin II-induced migration of vascular smooth muscle cells.

Authors:  Eun Young Shin; Chan Soo Lee; Mee Hee Park; Duk Joong Kim; Sahng June Kwak; Eung Gook Kim
Journal:  Exp Mol Med       Date:  2009-06-30       Impact factor: 8.718

9.  Inability of serotonin to activate the c-Jun N-terminal kinase and p38 kinase pathways in rat aortic vascular smooth muscle cells.

Authors:  A K Banes; R D Loberg; F C Brosius; S W Watts
Journal:  BMC Pharmacol       Date:  2001-10-08

Review 10.  The Mineralocorticoid Receptor in Salt-Sensitive Hypertension and Renal Injury.

Authors:  Nobuhiro Ayuzawa; Toshiro Fujita
Journal:  J Am Soc Nephrol       Date:  2021-01-04       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.